dr. bendell on remaining questions with regorafenib in hcc
Published 7 years ago • 101 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
3:48
clinical experience with regorafenib in hcc
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
0:55
dr. bendell on exciting advancements in the field of hcc
-
1:35
dr. bruix discusses the success of regorafenib in hcc
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
2:04
dr. bruix on regorafenib in second-line hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
6:20
response and outcomes with tkis in hcc
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
7:01
global use of regorafenib in hcc
-
4:32
therapeutic approach for hcc progression
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
7:09
global use of regorafenib in hcc